© Copyright Nostre Net
The global ultrasound devices market is expected to exhibit a strong 8.1% CAGR over the forecast period, rising to a valuation of USD 10.37 billion by 2023, according to a new report from Market Research Future (MRFR). The report elaborates on the major drivers and restraints for the global ultrasound devices market in detail by analyzing their impact on the market’s trajectory over the forecast period.
The growing demand for ultrasound devices for diagnostic purposes is likely to be the major driver for the global ultrasound devices market trends over the forecast period. Ultrasound devices work by sending out high-frequency sound waves that provide a picture of the targeted area based on the response of various bodily tissues to the sound waves. Since different tissues react differently to the same sound waves, the technique has become popular in the healthcare sector. The lack of invasion in the use of critical care ultrasound equipment has also become a key plus point for the market due to the growing obsession with minimally invasive and noninvasive medical procedures. Therapeutic applications of ultrasound include targeting a specific patch of tissue for stimulation or removal by bombarding it with high-frequency sound waves. This application is also likely to remain a key factor for the global ultrasound devices market’s growth over the forecast period.
The growing demand for more advanced ultrasound devices in the gynecology sector is likely to be a major driver for the global ultrasound devices market over the forecast period. The development of 3D and 4D ultrasound imaging has allowed for the diagnosis of congenital defects clearly and earlier in the pregnancy, which has made the procedures widely popular in the healthcare sector around the world. 4D imaging also allows live action viewing of the fetus, which allows physicians to detect more abnormalities. This is likely to be a major driver for the global ultrasound devices market over the forecast period.
Competitive Analysis:
Leading players in the global ultrasound devices market include Siemens AG, GE, Hitachi Ltd., Shimadzu Corporation, Analogic Corporation, Mindray Medical International Ltd., Toshiba Corporation, Samsung Electronics Co. Ltd., and Koninklijke Philips NV.
Leading players in the global ultrasound devices market are likely to focus on bringing about steady technological innovation and updation in their products in the coming years, as developing more modern products has become a key selling point in the industry. The rising threat of web-based intrusions is also likely to make companies focus more on technological updation. In March 2019, security specialist Check Point Software Technologies said in a report that ultrasound devices running on older operating systems such as Windows 2000 were virtually defenseless against modern hackers, which could result in the hackers gaining access to confidential hospital information and making exorbitant ransom demands on the hospital. Eliminating this threat is likely to be top of the agenda for the leading players in the global ultrasound devices market over the forecast period.
Segmentation Analysis:
By portability, cart/trolley-based devices accounted for the largest market share in 2017 due to its utilization in acute and emergency care settings. The segment is likely to register strong CAGR during the forecast period expected to hold significant market share during the forecast period. Handheld/compact ultrasound devices accounted for the second largest share due to the rising adoption of these by healthcare professionals.
By display, color devices accounted for a largest market share in 2017 compared to its counterpart, black/white ultrasound devices. The former can touch a size of USD 7,509.12 million by 2026, while the latter is likely to show prominent growth by the end of the forecast period.
By application, radiology/general imaging is likely to register highest CAGR during the assessment and likely to dominate the market by 2026. It accounted for the largest market share in 2017 due to its vast medical applications. The rising geriatric populace and incidence of various cancers can spur the segment growth. On the other hand, cardiology is also showing significant growth by 2026.
By technology, diagnostic accounted for the largest market share in 2017 due to the use of 2D ultrasound in women’s health. It is likely to show CAGR over the assessment period and hold significant market share by 2026 due to the continuous advances in imaging and reimbursement schemes for these procedures. On the flip side, therapeutic ultrasound is expected to hold second position by 2026.
By end-user, hospitals and diagnostic & surgical centers dominated the ultrasound devices market in 2017 due to emergence of various hospital chains and rising number of minimally invasive diagnostic procedures by doctors. The segment can grow with strong CAGR and expected to hold first position in the market. Ambulatory care centers can exhibit the highest CAGR of 3.61% during the forecast period thanks to the facilities providing same-day care diagnostic and surgical procedures.
Regional Analysis:
The Americas is likely to be the major regional market for ultrasound devices over the forecast period due to the widespread adoption of advanced ultrasound technology in the region and the growing demand for advanced diagnostic modalities and devices. Europe is also likely to remain a major regional market for ultrasound devices over the forecast period due to the growing healthcare expenditure in the region. Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the growing demand for advanced medical facilities and devices and the increasing investment in hospitals and medical technology.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Overview
Market Research Future (MRFR) says that the global gene expression analysis market could hold the value of USD 3.250 million by 2023. The market could also achieve a CAGR of 9.1% during the forecast period (2018-2023).
Growth Boosters and Key Restraints
Personalized medicine, with its ability to affect diagnostic and treatment decisions for every patient, has brought an evolution in modern medicine. Diagnosis, treatment, as well as lifestyle interventions, have now become progressively personalized to every patient genetics, family history along with other factors.
Technologies have made it easier for healthcare professionals to track every patient’s health information and offer personalized care. Personalized medicine has gained immense traction as a result of the boost in the number of genetic disorders. Additionally, the mounting awareness about this form of treatment will drive the market in the near future. The rising technological advancement including molecular services and NGS are uplifting the demand for gene expression services. This factor will ensure the success of the gene expression analysis market report during the evaluation period.
The downside could be the high cost of instruments, hindering the market growth in the review period. But the development of genomic databases, surge in government funding towards genomics, and increasing personalized medicine are projected to elevate the market position in the subsequent years.
Rising Investments in Gene Expression Analysis Researches
With single cell gene expression, genetic modifications recorded in animals like mice has given way to advancements in drug discover as well as development, clinical diagnostics and biotechnology, among others. Companies along with research institutes are working on projects based on gene expression analysis. These projects are seeing massive success backed by high investments as the demand for nucleic acid analysis, gene cloning & analysis, and other related microbiological methods is rising.
Leading Vendors
Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Pacific Biosciences of California, Inc., Illumina, Inc., Genotypic Technology Pvt Ltd, Danaher, QIAGEN, Oxford Gene Technology, Thermo Fisher Scientific, BGI, PerkinElmer Inc., Macrogen Inc., Eurofins Scientific, are some of the companies currently leading the worldwide gene expression analysis market.
Market Segmentation
The global market for epigenetics drugs has been segmented on the basis of product, services, application, and end-user.
The market, product-wise, include consumables and instruments.
Depending on consumables, the market covers reagents and DNA chips.
Instruments-based segments in the market are polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and others.
The services mentioned in the report are gene expression profiling services, sequencing services, bioinformatics solutions, and others.
Gene expression analysis finds applications in drug discovery, diagnosis, research, and others.
The end-users highlighted in the report are pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.
Regional Outlook
The primary markets for gene expression analysis are Europe, Asia Pacific, Middle East & Africa and the Americas.
During the forecast period, the Americas could very well reach the top position in the global gene expression analysis market, estimates MRFR. The highly-established infrastructure, huge expenditure, and increasing research and development activities in the region play a big role in this growth. The market also gets a boost from the large number of established players based in the region. Case in point is GE Healthcare, which alone generated revenue of USD 19.1 Billion in 2017.
Standing at the second spot, Europe is now an established region in the global gene expression analysis market. The regional market gains from the numerous government initiatives taken in research and development associated with gene expression analysis. Europe is also inundated with esteemed companies such as F. Hoffmann-La Roche Ltd. To illustrate, F. Hoffmann-La Roche, in February 2018, had received an approval from the U.S. Food and Drug Administration (FDA) for its multiplex Factor V and Factor II assessment which could be used on Cobas 4800 systems. This system is known for achieving real-time PCR analysis for high volume labs.
Asia Pacific could expect the fastest growth in the worldwide market. The rising number of global partnerships for the expansion of the region’s healthcare sector, government focus on cancer as well as life science research and internal manufacturing of the sequencing systems favors the regional market. Other factors promoting market growth could be the massive R&D investments and the booming bioresearch centers. On top of this, the surge in the number of research activities in agriculture and the growing approval of gene expression tests add to the market’s strength.
Middle East and Africa could project weak growth in the coming years on account of substandard healthcare amenities and low fund investments associated with research and development activities.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Opioids are medications prescribed by doctors and physicians to treat various levels of pain. These can include acute pain and chronic non-cancer pain. They are also known as painkillers and used to block pain signals from the brain. Market Research Future (MRFR) has stressed the advantages of the intake of opioids as well as the efforts by manufacturers to address various issues concerning the drugs.
Growth Drivers
The global opioids market share is slated to attain a valuation of USD 29,535.80 million by 2023, as per the latest report by MRFR. Pain management of various chronic diseases remain the primary driver of the market. According to the National Institute of Drug Abuse, nearly 200 million prescriptions were dispensed by U.S. pharmacies in 2017. The large number of prescriptions is an indicator for the large scope of the market.
Favorable reimbursement schemes for covering the costs of opioids in palliative care can work in favor of the market. Large number of patients diagnosed with various cancers can drive the market demand for opioids till 2023. Rise in surgical procedures and road accidents are other factors which can contribute to market demand due to the need for pain relievers. All of these factors are predicted to push the market to exhibit a CAGR of 7.12% during the forecast period.
Establishment of new guidelines to curb the intake of opioids and reduce the addiction rates are expecteFuture Perspective, Emerging Technologies And Analysis By Forecast to disrupt the market in a positive manner. For instance, the sale of over-the-counter drugs containing opioids is restricted, while stringent measures are undertaken regarding prescriptions given by doctors. New policies by government-supported insurance companies such as Medicare are limiting the dispensation rate of opioids to 7 days.
But misuse of opioid induced respiratory depression treatment and adverse effects of the drugs which lead to addiction threaten the market growth.
Segments In-Detail:
MRFR has segmented the global opioids market by product, application, and end-user.
Based on the product, the market is segmented into immediate release/short-acting opioid and extended release/long-acting opioid. Extended release comprises hydromorphone, oxycodone, morphine, oxymorphone, and others. The extended release segment had accounted for USD 12,750.91 million in 2017. This segment can expand in the coming years due to rising prevalence of chronic diseases.
By application, it is segmented into diarrhea suppression, deaddiction, cough suppression, pain relief, anesthesia, and others. The pain relief segment is expected to be the dominant application of the opioids market due to rise in pain management therapies. Moreover, new guidelines for selling prescription drugs coupled with rise in palliative and end-of-life care can boost segment growth. This in turn can drive the market demand exponentially.
By end-user, the market caters to academic research institutes, hospitals & clinics, and pharmacies.
Regional Analysis:
MRFR’s report takes a deep look into major regions which include the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).
The Americas is predicted to be dominant in the global market due to holding the largest market share due to awareness among patients and the high intake of the drugs for pain alleviation. On the other hand, Europe is expected to showcase prolific growth due to rise in palliative care centers and strict regulations regarding opioid usage.
Market Synopsis:
Market Research Future (MRFR)’s new analysis projects that the global healthcare chatbots market is set to witness healthy growth in the forthcoming years. The integration of Artificial Intelligence (AI) in the healthcare sector has paved the way for the adoption of chatbots. Additionally, healthcare chatbots are poised to handle complex tasks such as personal monitoring, appointment booking, etc. in an efficient manner and maximize the productivity of the organization. This, in turn, is expected to propel the expansion of the chatbots vs conversational ai.
The inclination towards cost cutting without compromising on the quality of services has accelerated the adoption of the technology in the healthcare sector. Additionally, the large-scale penetration of IT services has further catalyzed the growth of the top health chatbots market. The trend is projected to perpetuate over the next couple of years.
The compatibility of chatbots with mobile platforms has accelerated revenue creation for the players of the healthcare chatbots market application. The exponential demand for smartphones is prognosticated to drive the growth of the market significantly in the coming years.
Market Segmentation:
By component, the healthcare chatbots market has been segmented into software and services.
By deployment model, the global healthcare chatbots market is segmented into on-premise model and cloud-based model.
By application, the healthcare chatbots market has been segmented into symptom checking & medication assistance, and appointment scheduling & medical guidance.
By end user, the global healthcare chatbots market is segmented into patients, healthcare providers, insurance companies and others.
Regional Analysis:
By region, the global healthcare chatbots market has been segmented into Europe, North America, Asia Pacific, and the Rest of the World. North America is set to witness significant growth over the next couple of years. The factors responsible for favoring the growth of the regional market include rapid technological advancements, increasing adoption of artificial intelligence, consolidation of key players and presence of developed healthcare sector.
Europe is another important growth pocket of the global healthcare chatbot market. Rising healthcare expenditure coupled with increased research and development activities are set to aid the healthcare chatbots market proliferation in the region.
Asia Pacific is a highly lucrative market globally and is expected to remain so in the foreseeable future. The growth trajectory of the healthcare chatbots market in the region is guided by increasing investment in modernization of healthcare facilities and rising demand for advanced technologies in the healthcare sector. Meanwhile, the Middle East & Africa is set to exhibit little growth. The growth of the region is driven by Middle Eastern countries with developed healthcare sectors, while, the economically backward African regions remain impediments to market expansion.
Competitive Dashboard:
Some of the key players profiled in the report are Babylon Healthcare Service Limited (U.K.), PACT Care BV (Netherlands), Sensely, Inc. (U.S.), Buoy Health, Inc. (U.S.), Your.MD (U.K.), Infermedica (Poland), GYANT.Com, Inc. (U.S.), Ada Digital Health Ltd. (Germany), HealthTap, Inc. (U.S.), Baidu, Inc. (China), and Woebot Labs, Inc. (U.S.).
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Synopsis
Market Research Future (MRFR) asserts that the global autoimmune disease diagnostics market is likely to register a CAGR of 7.6% during the forecast period (2018-2023) owing to an increased prevalence of autoimmune diseases worldwide. Autoimmune disease is considered as a disorder where the body’s own immune system starts to attack the healthy cells in place of the foreign particles and disease-causing agents. Auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate are some of the tests performed for diagnosis of the autoimmune disease.
Market Potential and Pitfalls
The global autoimmune disease diagnostics market share is likely to experience an upsurge owing to the increased prevalence of autoimmune disease, surging awareness regarding autoimmune diseases, and rising expenditure on healthcare. The increasing spending on R&D activities coupled with the aggressive strategies adopted by the top market players like new product launches along with mergers and acquisitions are anticipated to contribute to the market growth across the globe. For instance, Abbott acquired Alere Inc. in October 2017 for USD 5300 million. The deal will enable Abbott to gain control over USD 7000 million diagnostics sales of Alere Inc. and also strengthen their position in the global market.
The increasing occurrences of several diseases like rheumatoid arthritis and Hashimoto’s thyroiditis are likely to influence the market across the globe. Several initiatives taken by the government regarding global spread of autoimmune disease are further contributing to its growth. As per the American Autoimmune Related Diseases Association, approximately 50 million people from America are suffering from autoimmune related disorders. Such factors are likely to create immense opportunities to the growth of the market.
Competitive Dashboard
The prominent players operating in the global autoimmune disease diagnostics market comprises bioMérieux SA, Siemens Healthcare Private Limited, Beckman Coulter Inc., Bio-rad Laboratories, EUROIMMUN AG, AstraZeneca, Inova Diagnostics Inc., F. Hoffmann-la Roche, Thermo Fisher Scientific, Myriad Genetics Inc., Hemagen Diagnostics Inc., and Trinity Biotech Plc.
Global Autoimmune Disease Diagnostics Market: Segmental Analysis
The global autoimmune disease diagnostics market has been segmented on the basis of test type, disease type, and end-user.
By mode of disease type, the global autoimmune disease diagnostics market has been segmented into systemic autoimmune disease, and localized autoimmune disease. Among these, the localized autoimmune disease segment is likely to gain prominence owing to the presence of large procedure volume and higher patient awareness level.
By mode of test type, the global autoimmune disease diagnostics market has been segmented into enzyme-linked immunosorbent assay (ELISA), western blotting, dot blot, double immune diffusion, line blot, counter immune-electrophoresis, multiplex immunoassay, immunofluorescence assays (IFA), agglutination, and others.
By mode of end-users, the global autoimmune disease diagnostics market has been segmented into diagnostics centers, hospitals, research laboratories, and others.
Regional Insights
Geographically, the autoimmune disease diagnostics market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.
Considering the global scenario, the American region is predicted to command the maximum share in the global market. The region is likely to retain its pole position owing to the surging prevalence of autoimmune diseases like rheumatoid arthritis. Moreover, the rising financial support by the private organizations and governments coupled with the adoption of high advanced technology in this region is anticipated to contribute to the growth of the market. As per a report published by the Arthritis Foundation in 2017, around 91 million Americans were suffering from arthritis, 300000 of them were children.
The European region is predicted to occupy the second spot in the global market owing to the increased automation in the laboratories, rising healthcare industry, and strategies implemented by the top market players like mergers & acquisitions and product launches.
The Asia Pacific region is likely to expand at the fastest growth rate during the assessment period. The growth can be ascribed to the inflating population, rising private-public partnerships for the improvement of the healthcare sector, and surging prevalence of autoimmune disorders in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The increasing number of joint replacement surgeries, particularly among the geriatric population, coupled with the growing adoption of minimally invasive surgeries, and striking advancement in healthcare facilities will have a strong impression on the growth of the osseointegration implants market in the coming years. Prominent players are constantly using various growth strategies like new product launch, partnerships, acquisitions, agreements and joint ventures for increasing their foothold in the industry. For instance, Integrum SE had introduced a revolutionary OPRA implant system in April 2018. As per the company, the product is expected to be initially available only in London and will be distributed via London International Patient Services (LIPS), which is a healthcare treatment organization for the international patients on the lookout for treatment.
The global osseointegration implants market trends is anticipated to post a CAGR of 6.4% over the forecast period of 2017-2023, proclaims Market Research Future (MRFR) in a detailed study. The global osseointegration implants market was stood at USD 4.7 Bn in 2017 and is expected to catapult to USD 6.8 Bn by the end of 2023.
Besides, the osseointegration implants market in the developed nations like the United States (U.S.), France, Germany, and Australia, is relatively more mature on account of the presence of well-established players thriving in these countries, accompanied by the high demand for these products.
Also, emerging nations in Latin America and Asia, at present, are witnessing a moderate adoption rate of osseointegration implants, serving to be strong growth opportunities in the near future. Moreover, economic growth paired with the growing disposable income in these economies will elevate the market position to a large extent. The market will further benefit owing to the manufacturing companies continuously investing in these rapidly emerging markets, on the face of various pricing and distribution activities being undertaken efficiently.
Competitive Landscape
Danaher Corporation, Zimmer Biomet Holdings Inc., NuVasive, Inc., Dentsply Sirona Inc., Cochlear Ltd., William Demant Holding A/S, The Straumann Group, Medtronic plc, Henry Schein Inc., Stryker Corporation are the notable players in the global osseointegration implants market.
Segmentation
The global osseointegration implants market has been segmented based on product, material type, and end user.
By product, the global osseointegration implants market has been segmented into bone-anchored prostheses, dental implants, and others. The bone-anchored prostheses segment is the largest segment while the osseointegration cost is the fastest-growing segment.
By material type, the global osseointegration implants market has been segmented into metallic, ceramic, polymeric and others. The metallic segment is the largest segment while the ceramic segment is expected to be the fastest growing segment.
By end user, the global osseointegration implants market has been segmented into hospitals, ambulatory surgical clinics, and others. The hospitals segment is the largest segment while the ambulatory surgical clinics segment is likely to be the fastest growing segment over the forecast period.
Regional Analysis
By region, the global osseointegration implants market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas account for the maximum share of the global osseointegration implants. Fast uptake of latest and technologically advanced treatment options, high healthcare expenditure, well spread awareness regarding osseointegration implants drive the market in the region. Moreover, the growing popularity of cosmetic dentistry and increase in geriatric population are also crucial factors boosting the market growth. The presence of key players is a factor which cannot be missed.
Europe too is a significant revenue pocket which is expected to expand notably over the forecast period.
APAC is expected to present lucrative growth opportunities for the growth of the osseointegration implants market. Increasing demand for these implants due to rapid top rise in geriatric population, and also high demand for dental implants spur the demand for osseointegration implants in the region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Steam autoclaves are equipment required for sterilization of medical supplies due to their non-toxic and inexpensive nature. The supplies are subjected to high-pressure steam levels for penetrating fabrics. The global steam autoclave market report by Market Research Future (MRFR) provides readers with substantial information on the current scenario as well as future prospects for the period during 2017 to2023.
Market Overview
The global steam autoclave market trends is anticipated to touch a size of significance by exhibiting a CAGR of 8.9% from 2017 to 2023 (forecast period). High prevalence of infections in hospitals and clinics are one of the biggest drivers of the market. The large number of hospital-acquired infections (HAI) has prompted governments to take measures to prevent the proliferation of infections. According to a survey by the Centers for Disease Control & Prevention (CDC), 1 in 3 people were diagnosed with HAI in 2018.
Emergence of life science laboratories to combat the menace of growing prevalence of chronic diseases can drive the steam autoclave market demand till 2023. The rising volume of biomedical waste generated from hospitals and other institutes in the medical sector is likely to trigger the need for sterilizing equipment. Development of novel technologies which can lower the production cost of steam autoclaves can bolster the market revenues. This is exemplified by the launch of new sterilization pouches for autoclave products capable of handling large volumes of equipment.
But strict regulations pertaining to disinfection and rise of disposable products can impede the market growth.
Competition Outlook
BMM Weston Ltd., Priorclave Ltd., Sterigenics International LLC, MATACHANA GROUP, Astell Scientific, PHC Corporation, Accumax India, Tuttnauer, Getinge AB, LTE Scientific Ltd, ZIRBUS technology GmbH, STERIS plc, Mar Cor Purification Inc., Belimed, Consolidated Sterilizer Systems, and others are reputed players of the global steam autoclave market. Mergers, acquisitions, and alliances are strategies followed by these players to sustain their position in the market.
Segmentation
The global steam autoclave market is segmented by product, technology, application, and end-user.
By product, it is segmented into high pressure, floor standing, table top, vertical, and horizontal.
Technologies discussed in the market report include steam flush pressure pulse, gravity displacement, and pre-vacuum.
Major applications include laboratory, medical, dental, and others.
End-users in the global steam autoclave market include academic and research institutes, hospitals and clinics, healthcare organizations, and others.
Regional Analysis
The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA) are regions taken into consideration during the compilation of the global steam autoclave market report.
The Americas can dominate the global market due to the increase in healthcare budget of prominent nations. Efforts taken by governments to prevent the proliferation of disinfection and further propagation of new diseases can drive the market demand. This is exemplified by the 2018 report by the Centers Medicare and Medicaid Services which stated the ballooning of the U.S. health expenditure to USD 3.3 trillion in 2016.
Europe is the second-largest region of potential to the market due to a well-defined healthcare regulatory framework and rollout of policies supporting cleanliness in hospital environments.
The APAC region is touted to exhibit the fastest growth rate during the forecast period due to the copious amount of medical waste generated annually in the developing economies of China and India. The large patient pool as well as the establishment of new hospital units by large medical hospitality service companies can trigger the need for steam autoclaves. The large healthcare budget of nations in the region is a positive indicator of the large potential for the global steam autoclave market till 2023.
The MEA region has the lowest market share due to large number of government initiatives developed to assist patients and improve the existing indoor environment of hospitals.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Synopsis:
Increasing burden of genetic disorders has raised awareness and encouraged investments for effective treatments. This, in turn, is likely to enable genotyping in gaining quick mileage over the next few years. According to the report circulated by Market Research Future (MRFR), the global genotyping market Trends is projected to register a CAGR of 22.5% during the assessment period 2018 to 2023.
Human genotyping is gaining momentum owing to the rising burden of genetic disorders. Also, the growing awareness about the same, coupled with the availability of government’s support, is expected to catalyze the proliferation of genotyping market. In addition, microorganism genotyping is expected to earn high revenues due to its extensive demand in the field of research & development. However, the lack of skilled personnel can pose a challenge to players of the plant genotyping.
Market Segmentation:
Based on technology, the global genotyping market has been segmented into sequencing, PCR, microarray, capillary electrophoresis, and mass spectrometry. The capillary electrophoresis segment is further sub-segmented into single-strand conformation polymorphism (SSCP), amplified fragment length polymorphism (AFLP), and restriction fragment length polymorphism (RFLP). The sequencing segment has been sub-segmented into pyrosequencing, next-generation sequencing, and Sanger sequencing. Also, the microarray segment has been sub-segmented into antibody microarrays, DNA microarrays, MM Chips, and peptide microarrays.
The segments of the genotyping market, based on product, include reagents and kits, services, and instruments.
The segmental analysis of the global genotyping market, on the basis of end-user, covers hospitals, academic institutes, diagnostic centers, and research and development centers.
Regional Analysis:
The global genotyping market, on the basis of region, has been segmented into four regions - Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). Americas is leading the growth of the global market and is expected to maintain its pole position over the next couple of years. The region has been observing an increase in the burden of genetic disorders. This, in turn, has encouraged investments in research & development projects which is poised to boost the expansion of genotyping market in the region. Alzheimer's Association published a report in 2018 stating that 5.7 million Americans had Alzheimer in that year. The same report revealed that the U.S. incurred a cost of USD 277 Bn for the disease. Other factors that are anticipated to accelerate revenue creation in the genotyping market in the region are the presence of developed healthcare industry, rising demand for personalized medicine, etc.
Europe is prognosticated to maintain its second-leading spot in the global market place across the review period. The genotyping market in the region is expected to get influenced greatly by the rising researches supported by the governments in the pharmaceutical industry. In addition, the rising cases of genetic disorders are also projected to favor market expansion in the region over the forecast period.
Asia Pacific is projected to expand at a relatively higher CAGR through the assessment period. The favorable laws implemented by the governments are encouraging investments in the genotyping market by global leaders. This, in turn, is likely to motivate the growth pattern of the regional market over the next couple of years.
Competitive Dashboard:
QIAGEN, Illumina, Inc, Affymetrix, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., General Electric Company, Fluidigm Corporation, F. Hoffmann-La Roche Ltd, Sequenom, and Beckman Coulter, Inc. are some of the leaders in the global genotyping market profiled in this MRFR report. These players are investing massive amounts in research & development activities. In addition, the exploration of the applications and potential of genotyping is further anticipated to boost the competition among these players. The growth trajectory of the genotyping market is likely to attract new entrants, thus, facilitating expansion and revenue generation. Strategies developed by the participants of the genotyping market for growth are mergers & acquisitions, collaborations, agreements, memorandum of understanding, increasing research activities, etc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Insight
Global Aptamers Market is getting steam from mainly the healthcare sector. The global aptamers market to triple its present market valuation during the forecast period 2018-2023, by climbing up at a CAGR of 20.2%, asserts Market Research Future in a well-analyzed report that includes a full description of the drivers and segments. The study also provides a proper perspective of the market in the coming years.
Market Trends & Drivers
The boom in Global Aptamers Market growth is rising at a rapid pace due to the ability to bind to the targeted lipid, protein, or nucleic acid molecules with high specificity. Therefore, its application base is likely to expand further in the coming years. The applications are generated rapidly and applied in the specific detection, inhibition, and characterization of proteins. With this, the aptamers are also be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules that leads the market to reach the highest level of valuation in the forecast period.
At the same time, the improvements in aptamer with development technologies, mounting Research and development expenditure, and growing number of companies investing in this market are some of the essential driving factors responsible for the growth of this market. In fact, the abundant advantages offered by these small molecules, in comparison to established antibodies, have also led the market to achieve higher demand for these molecules across medical applications. Such a factor has motivated the market to a great extent.
Furthermore, continuous advancement in technologies is likely to stimulate the growth opportunities of the market. On the flip side, the aptamers have somehow failed to meet the necessary safety and efficacy standards in clinical studies. With this, companies had to terminate the clinical investigation and thus, this factor remains to hamper the growth of this market in the forecast period.
Market Key Players
The well-known players in the global aptamers market are listed as Somalogic, Inc., Aptagen, LLC, Base Pair Biotechnologies, Inc., Aptamer Sciences, Inc., Am Biotechnologies, LLC, Ophthotech Corporation, Vivonics, Inc., Aptus Biotech S.L., Neoventures Biotechnology Inc., Aptamer Solutions Ltd., Trilink Biotechnologies, Inc., Noxxon Pharma.
Market Segmentation
The Global aptamer therapeutics Market’s segmental analysis has been conducted by type, application, technology, and end-users.
In terms of type: Nucleic acid aptamers and peptide aptamers are the segments. Wherein, the nucleic acid aptamers have further been segmented among DNA-Based Aptamers, RNA-Based Aptamers.
In terms of application: Diagnostics, therapeutics development, research and development, other applications are the segments.
In terms of technology: Selex, X-aptamer, and MARAS technique are the segments.
In terms of end-users: biotechnology and pharmaceutical companies, academic and government research institutes, contract research organizations are the segments.
Regional Outlook
Regionally, the global aptamers market has been studied among the critical regions of the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
North American region will be acquiring the largest market share owing to the early adoption of advanced medical technologies, high investment, and funding to support the development of aptamers. The extra factor, such as the upward demand for aptamer therapeutics coupled with a mount in several research laboratories, helps to boost the market.
The European market is also likely to acquire the second-largest market share. The factors such as a climb in research costs, advancement of technology, the turndown in human health, and the inevitability for innovative and effective therapies enhance the growth of the market in this region. The escalating number of small-scale start-ups, government organizations, expanding products under clinical investigation, as well as the rising number of academic research laboratories investigating, is anticipated to support the future growth of this market.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Blood group typing is a test used in determining the blood group of an individual. The need for frequent volumes of blood for patients admitted in hospitals, during surgeries, and blood disorders are likely to warrant for this type of test. The global blood group typing market report by Market Research Future (MRFR) highlights various factors and challenges which can assist investors in making a sizeable assessment.
Market Outlook
The global blood group typing Industry is expected to touch a towering valuation by exhibiting 10.2% CAGR from 2018 to 2023 (forecast period). High cases of road accidents, demand for blood and blood products, and need in prenatal testing are factors likely to drive the market growth. According to the American National Red Cross, close to 21 million blood components are transfused annually in the U.S.
Successful developments in biotechnology which can determine the probability of genetic disorders based on family and patient medical history can work in favor of the blood group typing market. Advances such as magnetic beads in assays and quantum dots are evident of technological advances. The use of blood typing in forensic sciences to discern identities of criminals can drive the market demand. Establishment of large blood banks to ensure a constant supply of blood combined with blood donation campaigns can influence the global market.
The uptick in the volume of major surgical procedures and blood donation rates are prominent drivers of the market. Increasing research and development activities for proper understanding of blood and antibody-antigens can culminate in high dividends. Demand for tests for early diagnosis and faster prognosis of chronic diseases can fuel the blood group typing market.
But lack of skilled professionals and strict rules for blood transfusion can impede market growth.
Competitive Outlook
Day Medical SA, Merck KGaA, AXO Science, Beckman Coulter, Agena Biosciences, Inc., Quotient, Ltd., Novacyt Group, Grifols International, S. A., Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, Inc., Immucor, Inc., Rapid Labs, Bag Healthcare GmbH, and others are some of the noteworthy players in the global blood group typing market. Novel product launches in the form of kits and collaborations are prime strategies by players to gain a competitive edge.
Segmentation Analysis
The global blood collection market is segmented by technique, test type, product and service, and end-user.
By technique, it is segmented into massively parallel sequencing, assay-based techniques, PCR-based and microarray technique, and others.
By test type, it is segmented into antigen typing, HLA typing, ABO blood tests, cross-matching tests, and antibody screening.
By product and service, it is segmented into instruments, consumables, services, blood bank saline, antisera reagents, anti-human globulin reagents, red blood cell reagents, and others.
By end-user, it is segmented into clinical laboratories, blood banks, hospitals, and others.
Regional Analysis
Europe, the Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions covered in the blood group typing market report.
The Americas is projected to dominate the global market due to large number of blood donations, rise in organ transplants, rising prevalence of chronic diseases, well-developed healthcare infrastructure, and reimbursement schemes for surgeries. According to the National Kidney Foundation in 2016, close to 121,678 patients in the U.S. were on the waiting list for organs.
Europe can assume the second position in the global market till 2022. Rising prevalence of hematological disorders and cases of blood cancer can collectively drive the regional market demand. According to the Office for National Statistics, nearly 8,208 people were diagnosed with leukemia.
The APAC region is predicted to exhibit experience growth at a relative fast pace due to the uptick in blood disorders, rising prevalence of chronic diseases, and continuously developing economies.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America